176 related articles for article (PubMed ID: 32154245)
1. Allergen Immunotherapy-Induced Immunoglobulin G4 Reduces Basophil Activation in House Dust Mite-Allergic Asthma Patients.
Feng M; Zeng X; Su Q; Shi X; Xian M; Qin R; Li J
Front Cell Dev Biol; 2020; 8():30. PubMed ID: 32154245
[TBL] [Abstract][Full Text] [Related]
2. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J
Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673
[TBL] [Abstract][Full Text] [Related]
3. Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy.
Feng M; Su Q; Lai X; Xian M; Shi X; Wurtzen PA; Qin R; Zeng X; Li J
J Immunol; 2018 Jun; 200(12):3897-3904. PubMed ID: 29728509
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of basophil activation test in diagnosis of Dermatophagoides farinae sensitization and evaluation of therapeutic efficacy of subcutaneous immunotherapy in children.
Li Y; Liu C; Li H; Wang X
Scand J Immunol; 2022 Aug; 96(2):e13168. PubMed ID: 35366340
[TBL] [Abstract][Full Text] [Related]
5. Specific immunoglobulin G4 correlates with Th2 cytokine reduction in patients with allergic asthma treated by Dermatophagoides pteronyssinus subcutaneous immunotherapy.
Su Q; Ren N; Feng M; Zeng X; Dong Y; Xian M; Shi X; Luo T; Liu G; Li J
World Allergy Organ J; 2023 Jan; 16(1):100715. PubMed ID: 36820309
[TBL] [Abstract][Full Text] [Related]
6. Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study.
Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
Int Arch Allergy Immunol; 2024; 185(1):73-78. PubMed ID: 37852197
[TBL] [Abstract][Full Text] [Related]
7. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
[TBL] [Abstract][Full Text] [Related]
8. Blocking function of allergen-specific immunoglobulin G, F(ab')
Zhang H; Xian M; Shi X; Luo T; Su Q; Li J; Feng M
Ann Allergy Asthma Immunol; 2022 Jun; 128(6):689-696. PubMed ID: 35405358
[TBL] [Abstract][Full Text] [Related]
9. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
Front Immunol; 2021; 12():786738. PubMed ID: 35197963
[TBL] [Abstract][Full Text] [Related]
10. Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis.
Huang J; Xiang R; Tan L; Deng Y; Tao Z; Zhang W; Xu Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111111. PubMed ID: 37925948
[TBL] [Abstract][Full Text] [Related]
11. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
Liu Y; Xing Z; Wang J; Geng C
Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
[TBL] [Abstract][Full Text] [Related]
12. The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
He Y; Liu J; Zhao D; Zhang S; Hao G; Sun Y; Zhong H; Chen H; Würtzen PA; Larsen JN; Lai X
Int Arch Allergy Immunol; 2021; 182(12):1231-1244. PubMed ID: 34280916
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal profiles of serum specific IgE and IgG4 to Dermatophagoides pteronyssinus allergen and its major components during allergen immunotherapy in a cohort of southern Chinese children.
Zeng G; Zheng P; Luo W; Huang H; Wei N; Sun B
Mol Immunol; 2016 Jun; 74():1-9. PubMed ID: 27111568
[TBL] [Abstract][Full Text] [Related]
14. Allergen-Specific IgE and IgG4 as Biomarkers for Immunologic Changes during Subcutaneous Allergen Immunotherapy.
Nikolov G; Todordova Y; Emilova R; Hristova D; Nikolova M; Petrunov B
Antibodies (Basel); 2021 Dec; 10(4):. PubMed ID: 34940001
[TBL] [Abstract][Full Text] [Related]
15. Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma.
Xian M; Feng M; Dong Y; Wei N; Su Q; Li J
Int Arch Allergy Immunol; 2020; 181(1):71-80. PubMed ID: 31722337
[TBL] [Abstract][Full Text] [Related]
16. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
[TBL] [Abstract][Full Text] [Related]
17. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
18. IgE and IgG4 Repertoire in Asymptomatic HDM-Sensitized and HDM-Induced Allergic Rhinitis Patients.
Xu Q; Jiang Q; Yang L; Li W; Huang N; Yang Y; Ma D; Zhang S; Wang Y; Zhu R
Int Arch Allergy Immunol; 2021; 182(12):1200-1211. PubMed ID: 34320489
[TBL] [Abstract][Full Text] [Related]
19. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.
Santos AF; James LK; Bahnson HT; Shamji MH; Couto-Francisco NC; Islam S; Houghton S; Clark AT; Stephens A; Turcanu V; Durham SR; Gould HJ; Lack G
J Allergy Clin Immunol; 2015 May; 135(5):1249-56. PubMed ID: 25670011
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
Hesse L; van Ieperen N; Habraken C; Petersen AH; Korn S; Smilda T; Goedewaagen B; Ruiters MH; van der Graaf AC; Nawijn MC
Allergy; 2018 Apr; 73(4):862-874. PubMed ID: 29318623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
